347 followers
New article delves into the crucial role of the TLR signaling pathway in B-cell and myeloid malignancies. Emavusertib, an IRAK-4 inhibitor, is emerging as a promising treatment, showing efficacy in B-cell NHL and myeloid cancers. https://t.co/owcf2ZRPAO